Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.05
Bid: 7.90
Ask: 8.20
Change: 0.05 (0.63%)
Spread: 0.30 (3.797%)
Open: 8.00
High: 8.05
Low: 7.65
Prev. Close: 8.00
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of InventionEvaluator.com

23 Jul 2014 14:51

RNS Number : 1405N
Tekcapital plc
23 July 2014
 



 

 

Tekcapital plc

("Tekcapital" or "the Company")

 

Tekcapital Acquires InventionEvaluator.com

to Support and Expand Corporate and University IP Service offerings

 

Tekcapital plc (AIM: TEK), an international provider of technology and IP services, is pleased to announce the acquisition of InventionEvaluator.com ("Invention Evaluator") and related intellectual property assets, including its website and client list (the "Acquisition") from Keon Research LLC and Ion Corp Pty Limited. The Acquisition is expected to be earnings enhancing in its first full year under Tekcapital's ownership and add forward revenue and profit to the Company in the near-term.

 

Strategic Rationale

 

As set out in its IPO Admission Document, as part of Tekcapital's growth strategy, the Company has been seeking to add additional services and expand its business, both organically and through accretive acquisitions. The Directors believe that the Acquisition meets this criterion and adds an important new product that is a useful follow-on service to Tekcapital's existing service offering and will also be sold as a stand-alone product.

 

Tekcapital's existing offering provides its retained clients with a complete turnkey solution to locate, screen and acquire technologies available for acquisition from the world's leading universities and research institutions across 160 countries. Once a suitable technology acquisition opportunity has been identified, the Company evaluates the IP through its expert Science Advisory Board and can then, if required, act as an intermediary between the client and the university or research institution with a view to the acquisition or licensing of the specific technology.

 

Invention Evaluator will integrate with Tekcapital's existing offering and enable Tekcapital to provide its clients with in-depth analytical reports that assess the commercial potential of new technologies and intellectual properties ("IP"). The bespoke reports enable companies and universities world-wide to make more informed decisions regarding investments in new technologies. For Tekcapital's existing customers, Invention Evaluator's reports will allow them to better understand the market potential for a new technology acquisition candidate. In addition to Tekcapital's existing and target customer base of IP acquisitive companies, the Directors believe that Invention Evaluator's product will be of interest to universities and research institutions and as a result will expand Tekcapital's relationships with these organisations.

 

Invention Evaluator was launched in 2010 by a company owned and operated by Dr. Michael Manion. Invention Evaluator has to-date served about 250 clients world-wide. Following the completion of the Acquisition, Dr. Manion and his team will continue to provide Invention Evaluator reports exclusively for Tekcapital.

 

Terms of the acquisition

 

Consideration in respect of the acquisition will be satisfied by the issue of 879,770 new ordinary shares in Tekcapital plc (the "Consideration Shares"). The Consideration Shares will be subject to lockup restrictions preventing their sale for a period of 12 months from the date of completion. Following completion of the Acquisition, the assets will be held via Tekcapital's wholly owned U.S. subsidiary, Tekcapital LLC. Under the ownership of its developer, Invention Evaluator had not yet become profitable. Within the overall suite of Tekcapital's offering it will be given a wider market exposure and the aim is for it to contribute significantly.

 

Application has been made for the Consideration Shares to be admitted to trading on AIM and dealings are expected to commence on 29 July 2014.

 

Total voting rights

 

Following admission of the Consideration Shares, Tekcapital's total issued and voting share capital will comprise of 23,383,747 ordinary shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, securities of the Company.

    

Commenting on the acquisition, Dr. Clifford Gross, Executive Chairman of Tekcapital plc, said:

 

"We are very pleased to announce the acquisition of InventionEvaluator.com and believe that this unique service will be of benefit to current and future clients seeking to understand the marketplace value of new technology acquisitions.

 

"This transaction underscores our commitment to growing our business through the acquisition of synergistic, scalable services that help our clients profit from university technologies."

 

Dr. Michael Manion, the founder of Invention Evaluator, added:

 

"We are enthusiastic about the transaction and believe that by working with Tekcapital we will be able to grow faster and penetrate additional markets with our service offering."

 

To learn more about Invention Evaluator please visit www.inventionevaluator.com

 

- ENDS-

 

For further information please contact:

 

 

Tekcapital Plc

via FTI Consulting, LLP

Clifford Gross, Executive Chairman

cgross@tekcapital.com

Malcolm Groat, Finance Director

mgroat@tekcapital.com

Northland Capital Partners Limited (NOMAD & Broker)

+44 (0) 20 7382 1100

Louis Castro / Lauren Kettle (Corporate Finance)

lcastro@northlandcp.co.uk

John Howes / Alice Lane (Corporate Broking)

Optiva Securities Limited (Co-Broker)

+44 (0) 20 3137 1904

Jeremy King / Vishal Balasingham

jeremy.king@optivasecurities.com

FTI Consulting, LLP

+44 (0) 20 3727 1000

Chris Lane / Emma Appleton / Roger Newby

chris.lane@fticonsulting.com

 

* * * * *

 

About Tekcapital plc - The World's Largest University Network for Open Innovation

 

Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 3,300+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage. Tekcapital plc is listed on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUOVORSRABUAR
Date   Source Headline
2nd May 20247:00 amRNSPortfolio Company Update Guident Q1 2024
26th Apr 20247:00 amRNSInnovative Eyewear Canadian Partnership
25th Apr 20247:00 amRNSInnovative Eyewear Patent Filings
18th Apr 20247:00 amRNSInnovative Eyewear Signs Brand Ambassador
17th Apr 20247:00 amRNSInnovative Eyewear Distribution Partnership
9th Apr 20247:00 amRNSPortfolio Company Update : Guident Ltd
5th Apr 20247:00 amRNSPortfolio Company Update : Guident Ltd
28th Mar 202410:20 amRNSNotification of Major Holdings
7th Mar 202411:15 amRNSNotification of Major Holdings
6th Mar 20247:00 amRNSIntellectual Property Update
29th Feb 20247:51 amRNSFundraising of £2.0 million
19th Feb 20247:00 amRNSPortfolio Company Update : Guident Ltd
15th Feb 202410:31 amRNSNotification of Major Holdings
15th Feb 20247:00 amRNSGuident Expands its Strategic Partnership
13th Feb 20242:24 pmRNSNotification of Major Holdings
1st Feb 20247:15 amRNSMicroSalt Admission to AIM First Day of Dealings
1st Feb 20247:01 amRNSNotice of Presentation on Investor Meet Company
24th Jan 20247:00 amRNSBellescura Plc - Disposal of Shares
12th Jan 20244:31 pmRNSLoan Agreement with Innovative Eyewear Inc
11th Jan 20247:00 amRNSInnovative Eyewear Patent Applications
9th Jan 20247:00 amRNSMicroSalt expand Placement Low Sodium Salt Shakers
22nd Dec 20237:00 amRNSAnnual Corporate & Strategy Update
14th Dec 20237:00 amRNSInnovative Eyewear Appoints Brand Ambassador
13th Dec 20237:00 amRNSInnovative Eyewear Update for Android ChatGPT App
12th Dec 20237:00 amRNSInnovative Eyewear,Inc. Global Licensing Agreement
17th Nov 20237:00 amRNSInnovative Eyewear Launches Upgraded Charging Dock
16th Nov 202312:12 pmRNSForm 8.3 - Belluscura PLC
1st Nov 20237:00 amRNSMicroSalt placement SaltMe! Crisps in MR Williams
19th Oct 20237:00 amRNSMicroSalt placement of SaltMe Low Sodium Crisps
17th Oct 20237:00 amRNSInnovative Eyewear Launches New Collection
16th Oct 20237:00 amRNSTakeover Code Form 8.3 - Belluscura plc
5th Oct 20237:00 amRNSBelluscura Update
5th Oct 20237:00 amRNSNotification of Major Holdings
3rd Oct 20238:00 amRNSMicroSalt Primary Bid Offer Files Schedule One
29th Sep 20238:00 amRNSHalf Yearly Report for period ending 30 June 2023
19th Sep 20237:00 amRNSMicroSalt Partnership with Weijohn Farms Group
13th Sep 20234:15 pmRNSNotification of Major Holdings
11th Sep 20237:00 amRNSInnovative Eyewear Announces Patent Filing
7th Sep 20237:00 amRNSMicroSalt files New Patent to Improve Baked Goods
6th Sep 20237:00 amRNSGuident Update
24th Aug 20237:00 amRNSPortfolio Company Update - Guident
17th Aug 20237:00 amRNSPortfolio Companies Update
14th Aug 20237:00 amRNSLucyd ChatGPT App Update for Smart Eyewear
1st Aug 20237:00 amRNSInnovative Eyewear Launches Lucyd Blueshift Lens
31st Jul 20237:00 amRNSMicroSalt commercial orders for SaltMe Crisps
30th Jun 20237:00 amRNSInnovative Eyewear Miami Fashion Week
28th Jun 20237:00 amRNSInnovative Eyewear Partnership with PRIVATO
26th Jun 20237:00 amRNSMicroSalt Expands U.S. Retail Network
22nd Jun 20231:38 pmRNSResults of Annual General Meeting
22nd Jun 20231:27 pmRNSInnovative Eyewear US$ 4.7Million Public Offering

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.